| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |